Viral Vector Manufacturing

VectorBuilder has extensive expertise in producing various types of viral vectors for cell and gene therapy development. We offer these at various scales and quality attributes to meet the full range of demands along the gene therapy drug development pipeline. Our team has established and validated platform technologies for large-scale GMP manufacturing of adeno-associated virus (AAV) and lentivirus, and we also have the expertise and capacity for manufacturing other types of viral vectors such as adenovirus, MMLV, herpes simplex virus (HSV), and vesicular stomatitis virus (VSV).

Highlights

Experts in Virus Packaging Experts in Virus Packaging Proprietary technologies optimized to achieve the highest titer and potency at any scale.
Scalable Solutions Scalable Solutions Versatile platform to support your production needs, from research to commercial grades.
Highest Quality and Consistency Highest Quality and Consistency State-of-the-art GMP facilities and equipment providing the highest purity and consistency.

Grades of Viral Vectors Offered

We produce viruses in several grades to cover a full range of downstream applications including drug discovery research, preclinical studies, clinical trials, and commercialization.

     R&D
     Preclinical
     Clinical
     Commercial
  • Suitable for basic research, such as studies in gene function and regulation, and drug discovery studies
  • Produced in conventional cell culture facilities with stringent QC
  • Suitable for preclinical studies (e.g. animal testing of drug safety and metabolism)
  • Produced in PAS or GMP facilities in a manner that adopts key features of GMP guidelines
  • Can be produced under antibiotic-free and animal component-free conditions
  • Suitable for preclinical studies, clinical studies, and commercialization
  • Produced in our certified GMP suite with strict adherence to GMP guidelines
  • Includes comprehensive and customizable QC assays and batch release report

Comparison of different grades of virus

AAV
Lentivirus
Research-Grade  GMP-Like  GMP-Grade 
Applications Basic research, drug discovery, and preclinical studies Preclinical studies such as animal testing of drug safety and metabolism Preclinical studies, clinical studies, and commercialization
Production scales 5x1010 to 1014 GC per batch 5x1013 to 1017 GC per batch 1014 to 1017 GC per batch
Turnaround time 10-50 days 4-5 months 6-12 months
Production site In parallel production in standard BSL-2 laboratory Produced in segregated BSL-2 production suites Produced in certified GMP suites (BSL-2)
Quality system ISO9001 ISO9001 while adopting key features of GMP manufacturing ICH quality guidelines for GMP manufacturing
Document control and traceability No Yes Full traceability
Vector characterization RE digestion, insert sequencing RE digestion, full-length sequencing RE digestion, full-length sequencing
Process development No Performed on a case-by-case basis depending on individual project needs Yes
Cell banking No Available upon request Yes
Antibiotic-free No Available upon request Yes
Animal component-free No Available upon request for suspension culture For suspension culture
Purification Ultracentrifugation Ultracentrifugation, affinity purification, IEX purification, mixed-mode chromatography Ultracentrifugation, affinity purification, IEX purification, mixed-mode chromatography
QC and release tests Titer measurement, SDS-PAGE, endotoxin detection, sterility testing, mycoplasma detection, etc. Performed on a case-by-case basis depending on individual project needs Full panel QC assays, analytical development upon individual project needs
Aseptic fill/finish No Available upon request Yes
Storage of retain sample Available upon request Available upon request Yes
Document deliverable COA 1. COA
2. Manufacturing summary
3. TSE/BSE statement upon request
1. COA
2. TSE/BSE statement
3. CTD documents
4. Others (BMR etc.) upon request
Research-Grade  GMP-Like GMP-Grade
Applications Basic research, drug discovery, preclinical studies Preclinical studies such as animal testing of drug safety and metabolism Preclinical studies, clinical studies, and commercialization
Production scales >2.5x107 TU 109 to 1012 TU per batch 5x109 to 1012 TU per batch
Turnaround time 8-16 days 4-5 months 6-12 months
Production site In parallel production in standard BSL-2 laboratory Produced in segregated BSL-2 production suites Produced in certified GMP suites (BSL-2)
Quality system ISO9001 ISO9001 while adopting key features of GMP manufacturing ICH quality guidelines for GMP manufacturing
Document control and traceability No Yes Full traceability
Vector characterization RE digestion, insert sequencing RE digestion, full-length sequencing RE digestion, full-length sequencing
Process development No Performed on a case-by-case basis depending on individual project needs Yes
Cell banking No Available upon request Yes
Antibiotic-free No Available upon request Yes
Animal component-free No Available upon request for suspension culture For suspension culture
Purification Ultracentrifugation Ultracentrifugation, affinity purification, IEX purification, mixed-mode chromatography Ultracentrifugation, affinity purification, IEX purification, mixed-mode chromatography
QC and release tests Titer measurement, sterility testing, mycoplasma detection, etc. Performed on a case-by-case basis depending on individual project needs Full panel QC assays, analytical development upon individual project needs
Aseptic fill/finish No Available upon request Yes
Storage of retain sample Available upon request Available upon request Yes
Document deliverable COA 1. COA
2. Manufacturing summary
3. TSE/BSE statement upon request
1. COA
2. TSE/BSE statement
3. CTD documents
4. Others (BMR etc.) upon request

Workflow for GMP Production of Viral Vectors

VectorBuilder strives to deliver products of the highest quality on time. Here is a typical GMP production workflow of viral vectors:

Vector characterization > Process development and cell banking > Plasmid production > Quality control and release.
Vector
Characterization
Process
Development
&
Cell
Banking
&
Plasmid
Production
Engineering
Run
GMP Run
QC & Release
1 week
2.5 months
1 month
1 month
1 month
  • RE digestion
  • Sequencing
  • Cell line
    development
  • USP/DSP
  • Analytical
    development
  • RCB
  • MCB
  • WCB
  • Segregated
    suite
    (GMP-like)
  • GMP suite
    (GMP-grade)
  • Closed system
  • Fill/finish
  • General/physical
    properties
  • Identity
  • Purity
  • Safety

Platform Technologies

AAV Platform
Lentivirus Platform

AAVs are packaged in HEK293 cells under either adherent conditions (multi-layer flasks or fixed-bed bioreactors) or serum-free suspension conditions (up to 200 L single-use bioreactors). Upon request, we can also package AAV in suspension Sf9 insect cells. We are capable of production scales reaching up to 1017 GC AAV per batch.

Cell Bank recovery and culture > Fermentation > Harvest and lysis > Centrifugation > Chromatography > TFF > Sterile filtration > QC
Adherent
(Multi-layer flasks,
fixed-bed bioreactors)
Suspension
(Single-use bioreactors)
Transfection
(PEI, calcium
phosphate
Harvest and
lysis
Clarification and
concentration

(TFF)
Purification
(Chromatography)
Formulation
(TFF, sterile
filtration, fill/finish)
QC and release

Lentivirus packaging (2nd or 3rd generation, pseudotyped with VSV-G or other viral surface proteins) is performed in HEK293 cells under either adherent conditions (multi-layer flasks or fixed-bed bioreactors) or serum-free suspension conditions (up to 200 L single-use bioreactors). We are capable of production scales of up to 1012 TU per batch.

Cell Bank recovery and culture > Fermentation > Harvest and alkaline lysis > Centrifugation > Chromatography > TFF > Sterile filtration > QC
Adherent
(Multi-layer flasks,
fixed-bed bioreactors)
Suspension
(Single-use bioreactors)
Transfection
(PEI, calcium
phosphate
Clarification and
concentration

(TFF)
Purification
(Chromatography)
Formulation
(TFF, sterile
filtration, fill/finish)
QC and release

For more information on our manufacturing platform and/or GMP capabilities, contact the VectorBuilder service team.

Talk to Our Experts

Analytical Methods

Quality control assays

The table below summarizes the default QC assays (marked with ✓) for the release of GMP-like and GMP-grade viral vectors. Optional QC assays are performed depending on individual project needs.

AAV Platform
Lentivirus Platform
Attribute QC Assay GMP-Like GMP-Grade
General/Physical Properties Osmolality Freezing point depression Optional
pH pH meter
Particulate matter Light obscuration particle count test Optional
Appearance Visual inspection Optional
Extractable volume Direct measurement Optional
Physical titer qPCR
ddPCR Optional
ELISA
Infectious titer TCID50 Optional Optional
Potency mRNA transcription RT-qPCR Optional
RT-ddPCR Optional Optional
Protein expression Flow cytometry (FCM) Optional Optional
Identity Full-length plasmid sequence Sanger sequencing
NGS Optional Optional
Third-generation sequencing Optional Optional
Purity Capsid protein purity SDS-PAGE with silver staining
Empty capsid ratio Transmission electron microscopy (TEM) Optional Optional
Mass photometry (MP)
Analytical ultracentrifugation (AUC) Optional
Charge detection mass spectrometry (CDMS) Optional Optional
Aggregation Dynamic light scattering (DLS) Optional Optional
Size exclusion chromatography (SEC) Optional
Genome integrity Alkaline gel electrophoresis
Process-Related Impurity Residual plasmid DNA qPCR
ddPCR Optional Optional
Residual host cell DNA qPCR
Residual E1A sequence qPCR
Residual host cell DNA fragment  size Capillary electrophoresis (CE) Optional
Residual host cell proteins ELISA
Residual Benzonase ELISA
Residual affinity ligand HPLC Optional Optional
Residual transfection reagent HPLC Optional Optional
Residual ultracentrifugation agent HPLC Optional
Residual detergent HPLC Optional Optional
Product-Related Impurity Replication competent AAV qPCR Optional
Safety Sterility Direct inoculation Optional Optional
Membrane filtration sterility test
Endotoxin Kinetic chromogenic assay (KCA)
Mycoplasma DNA staining Optional
qPCR Optional
Direct culture and indicator cell culture Optional
Adventitious virus testing Cell culture (using MRC-5, VERO, and HEK293 cells) Optional
Documentation - -
1. COA
2. Manufacturing summary
3. TSE/BSE certificate upon request
1. COA
2. TSE/BSE certificate
3. CTD documents
4. Others (BMR, etc.) upon request
Attribute QC Assay GMP-Like GMP-Grade
General/Physical Properties Osmolality Freezing point depression Optional
pH pH meter
Particulate matter Light obscuration particle count test Optional
Appearance Visual inspection Optional
Extractable volume Direct measurement Optional
Physical titer RT-qPCR Optional
ELISA
Functional titer qPCR
Flow cytometry (FCM) Optional
Infectious titer TCID50 Optional Optional
Potency mRNA transcription RT-ddPCR Optional Optional
Protein expression Flow cytometry (FCM) Optional Optional
Identity Full-length plasmid sequence Sanger sequencing
NGS Optional Optional
Third-generation sequencing Optional Optional
Purity Aggregation Dynamic light scattering (DLS) Optional Optional
Process-Related Impurity Residual plasmid DNA qPCR
ddPCR Optional Optional
Residual host cell DNA qPCR
Residual E1A sequence qPCR
Residual SV40 LTA sequence qPCR
Residual host cell DNA fragment  size Capillary electrophoresis (CE) Optional
Residual host cell proteins ELISA
Residual Benzonase ELISA
Residual affinity ligand HPLC Optional Optional
Residual transfection reagent HPLC Optional Optional
Residual detergent HPLC Optional Optional
Product-Related Impurity Replication competent lentivirus Cell culture Optional
Safety Sterility Direct inoculation Optional Optional
Membrane filtration sterility test
Endotoxin Kinetic chromogenic assay (KCA)
Mycoplasma DNA staining Optional
qPCR Optional
Direct culture and indicator cell culture Optional
Adventitious virus testing Cell culture (using MRC-5, VERO, and HEK293 cells) Optional
Documentation - -
1. COA
2.Manufacturing summary
3.TSE/BSE certificate upon request
1. COA
2. TSE/BSE certificate
3. CTD documents
4. Others (BMR, etc.) upon request

Additional QC services not listed above may be provided upon request. Please contact our service team for more details.

Talk to Our Experts
Stability studies

Drug stability studies are performed following ICH guidelines. Forced degradation studies are performed to evaluate the influence of light, temperature, pH, etc., on the quality attributes of the viral vector DNA.

Our Facilities

VectorBuilder currently has about 100,000 ft2 of modern GMP-compliant facilities with advanced designs and state-of-the-art equipment meeting GMP regulations of US, EU, Japan, China, and PIC/S. Our facilities comply with ICH guidelines and are suitable for GMP production for Phase I/II/III clinical trials.